Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
Satoru Hasegawa(Nagoya University), Masaaki Hirayama(Chubu University)
Cited by 530
Related Papers
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
|PLoS ONE|2017|247
Pilot study of H<sub>2</sub> therapy in Parkinson's disease: A randomized double‐blind placebo‐controlled trial
|Movement Disorders|2013|158